13
Nov
2017
NousCom’s Neoantigen-based Vaccine Synergizes with NKTR-214 to Cure Established Tumors in Preclinical Model


06
Nov
2017
NousCom Raises €42 Million Series B Financing


26
Sep
2016
Nouscom Appoints New Chief Operating Officer and Strengthens the Board of Directors


17
May
2016
NousCom concludes successful series A financing of EUR 12 million